AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 65 filers reported holding AVROBIO INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $13,000 | -81.9% | 1,120 | -76.8% | 0.00% | – |
| Q4 2020 | $72,000 | +242.9% | 4,834 | +233.6% | 0.00% | – |
| Q3 2020 | $21,000 | -51.2% | 1,449 | -41.4% | 0.00% | – |
| Q2 2020 | $43,000 | -17.3% | 2,473 | -5.0% | 0.00% | – |
| Q4 2019 | $52,000 | +100.0% | 2,604 | +44.0% | 0.00% | – |
| Q3 2019 | $26,000 | +23.8% | 1,808 | +37.1% | 0.00% | – |
| Q2 2019 | $21,000 | +2000.0% | 1,319 | +1382.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 89 | +111.9% | 0.00% | – |
| Q3 2018 | $2,000 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,930,704 | $42,572,000 | 24.97% |
| Aisling Capital Management LP | 811,998 | $17,905,000 | 13.64% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $4,753,000 | 1.30% |
| Eventide Asset Management | 928,891 | $20,482,000 | 0.70% |
| EMERALD ADVISERS, LLC | 614,408 | $13,548,000 | 0.55% |
| Virtus ETF Advisers LLC | 10,850 | $239,000 | 0.51% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 522,590 | $11,523,000 | 0.46% |
| Cormorant Asset Management, LP | 300,000 | $6,615,000 | 0.45% |
| Blackstone Inc. | 2,962,325 | $65,319,000 | 0.32% |
| FARALLON CAPITAL MANAGEMENT LLC | 900,000 | $19,845,000 | 0.15% |